Bosentan in Children With Pulmonary Arterial Hypertension Extension Study

Mise à jour : Il y a 4 ans
Référence : NCT00319020

Femme et Homme

Extrait

The main objective of the FUTURE-2 study was to assess the long-term safety and tolerability of the pediatric formulation of bosentan in children with idiopathic pulmonary arterial hypertension or familial pulmonary arterial hypertension who completed FUTURE-1 study.


Critère d'inclusion

  • pulmonary arterial hypertension


Liens